[HTML][HTML] Real-world treatment patterns, overall survival, and occurrence and costs of adverse events associated with second-line therapies for Medicare patients with …
A Arunachalam, H Li, MA Bittoni, R Camacho, X Cao… - Clinical Lung Cancer, 2018 - Elsevier
Introduction Real-world data on current treatment practices for non–small-cell lung cancer
(NSCLC) are needed to understand the place in therapy and potential economic impact of …
(NSCLC) are needed to understand the place in therapy and potential economic impact of …
Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With Second-Line Therapies for Medicare Patients With …
A Arunachalam, H Li, MA Bittoni, R Camacho… - Clinical Lung …, 2018 - europepmc.org
Results We identified 4033 patients with advanced NSCLC who received second-line
therapy (47% of those who received first-line platinum-based chemotherapy). Mean (SD) …
therapy (47% of those who received first-line platinum-based chemotherapy). Mean (SD) …
[HTML][HTML] Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With Second-Line Therapies for Medicare Patients …
A Arunachalam, H Li, MA Bittoni… - Clinical Lung …, 2018 - clinical-lung-cancer.com
Introduction Real-world data on current treatment practices for non–small-cell lung cancer
(NSCLC) are needed to understand the place in therapy and potential economic impact of …
(NSCLC) are needed to understand the place in therapy and potential economic impact of …
Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With Second-Line Therapies for Medicare Patients With …
A Arunachalam, H Li, MA Bittoni… - Clinical Lung …, 2018 - ohiostate.elsevierpure.com
Abstract This Surveillance, Epidemiology, and End Results–Medicare analysis included
4033 patients receiving second-line therapy after first-line platinum-based therapy for newly …
4033 patients receiving second-line therapy after first-line platinum-based therapy for newly …
Real-World Treatment Patterns, Overall Survival, and Occurrence and Costs of Adverse Events Associated With Second-Line Therapies for Medicare Patients With …
A Arunachalam, H Li, MA Bittoni… - Clinical lung …, 2018 - pubmed.ncbi.nlm.nih.gov
Introduction Real-world data on current treatment practices for non-small-cell lung cancer
(NSCLC) are needed to understand the place in therapy and potential economic impact of …
(NSCLC) are needed to understand the place in therapy and potential economic impact of …